Trial Profile
A Relative Bioavailability Study of 500 mg Divalproex Sodium Extended Release Tablets Under Fasting Conditions.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary) ; Valproic acid
- Indications Bipolar disorders; Epilepsy; Migraine
- Focus Pharmacokinetics
- 11 Sep 2009 New trial record